Skip to main content

Market Research Outlook

MRO Tracker · Pharma

Monthly and half year pharmaceutical exports, by product group and region. Updated when official monthly trade data is released.

USD 16.14 bnexports in H1 FY27, +4.9%
USD 2.74 bnSeptember 2026, +4.68%
73.84%share of formulations and biologicals
+12.07%growth in bulk drugs and intermediates
MRO View: Growth has slowed from 9.4% in FY25 to under 5% this half, as shipments to the US moderated. The fastest gains came from ASEAN, Latin America and Europe, and bulk drugs grew more than three times as fast as formulations.

Headline numbers

PeriodExportsGrowth
H1 FY27 (Apr to Sep 2026)USD 16,135.93 mn4.9%
H1 FY26 (Apr to Sep 2025)USD 15,382.85 mn
Q2 FY27 (Jul to Sep 2026)USD 8.04 bn3.05%
September 2026USD 2,744.05 mn4.68%
FY25 full yearUSD 30.47 bn9.4%

By product group, H1 FY27

GroupExportsShareGrowth
Drug formulations and biologicalsUSD 11.91 bn73.84%3.81%
Bulk drugs and drug intermediatesUSD 2.75 bn17.0%12.07%
SurgicalsUSD 427 mn2.6%9.53%

Growth by region, H1 FY27

Pharma export growth by region
ASEAN21.54%
Latin America and Caribbean16.58%
Europe (20.38% of total)9.66%
Africa6.48%
RegionExportsGrowth
ASEANGrowth only21.54%
Latin America and CaribbeanGrowth only16.58%
Europe (20.38% of total)USD 3,288.27 mn9.66%
AfricaGrowth only6.48%
North America, incl. United StatesGrowth onlyModerated

Region values other than Europe are not part of the half year release; growth rates are shown so the direction of each market is clear. Shares of bulk drugs and surgicals are MRO calculations on the H1 total. The tracker is refreshed each month when new export data is released.

Need the numbers behind this tracker?

We break down export demand by molecule, country and buyer for pharma clients.

Get the monthly India tracker updateNew state data and new plant announcements in one short email, once a month.

One email a month. Reply to any email to unsubscribe. Privacy policy